Limiting Imaging Time Helps Prevent Exposure of Heart Patients to COVID-19
The COVID-19 pandemic has led to a multi-dimensional strain on echocardiography laboratories and echocardiography service providers. Healthcare professionals and their greater community are found to thoroughly scrutinize how care is delivered in hospitals and clinics. Companies in the echocardiography market are boosting their efforts to create awareness about insights from the past when pandemics, such as SARS, had grappled the global healthcare community.
Patients with heart diseases are at a high risk of falling prey to the novel coronavirus infection. Hence, stakeholders in the echocardiography market are increasing efforts to maintain robust supply of echocardiography devices to prevent compromise on patient care and diagnosis. Stakeholders and healthcare associations are educating clinicians to limit the exposure time of imager devices and increase the use of point-of-care (POC) devices.
ML Research Holds Promising Potentials for Automated Echo Analysis, Interpretation Systems
The echocardiography market is projected to cross a revenue of US$ 2.2 Bn by 2030. A plethora of algorithms are being proposed to analyze medical ultrasound data using signal processing and machine learning (ML) techniques. However, there is a need to develop robust systems suitable for efficient use in clinical settings of point-of-care testing. Thus, med-tech companies in the echocardiography market are bolstering their R&D activities to advance in the field of automatic echo analysis.
It has been found that machine learning algorithms are being used by med-tech companies to develop automated echo analysis and interpretation systems.
Point-of-care Ultrasound Accelerates Cardiac Scanning with Auto Labeling, Guiding
Over the past few years, cardiac ultrasound vendors in the echocardiography market have introduced several new products to accelerate the flow of cardiac imaging. Artificial intelligence (AI) is becoming a fast growing phenomenon in the field of echocardiography, which is helping to automate the functions of devices and systems. EchoNous— a software development company is gaining recognition for its Kosmos system, which delivers point-of-care ultrasound (POCUS) by uniting AI with handheld ultrasound that empowers physicians to act quickly.
Companies in the echocardiography market are teaming up with software companies to develop AI apps that are capable of calculating ejection fraction in seconds. These apps are accelerating medical diagnosis, as they support physicians through cardiac scanning with auto labeling, guiding, and grading.
Advancements in Pulse Doppler Help Deliver High Resolution Heart Images
The concept of handheld ultrasound is growing popular in the echocardiography market. Echocardiography is emerging as a substantial competitive threat to diagnostic nuclear cardiology. On the other hand, advancements in pulse Doppler are enabling reliable probes that could be inserted into the esophagus to improve the resolution of heart images. Companies in the echocardiography market are increasing their R&D in acoustic quantification of techniques that help detect and monitor the boundary between the inner edge of the myocardium and blood pool.
Healthcare companies are taking additional efforts to increase accuracy of echocardiography outcomes that can determine the amount of blood supplied to different regions of the heart walls.
Miniature Probes to Displace Angiography for Coronary Artery Disease Diagnosis
Companies in the echocardiography market are innovating in miniature probes that can be inserted into the heart through the coronary vasculature. Analysts at the are deep diving into insights given by clinicians who predict that intraluminal ultrasound imaging using miniature probes will eventually displace angiography as the gold standard for coronary artery disease diagnosis.
Med-tech companies in the echocardiography market are attempting to use ultrasound signal to characterize tissues through which, the signal has passed. Such innovations hold promising potentials to identify tumors and distinguish between scar tissue and ischemic myocardium. Echocardiography is posing as a direct competitor to nuclear cardiology, owing to the former’s detailed assessments of movement in segments of the left and right ventricles of the heart.
Analysts’ Viewpoint
Echocardiography innovations involving automation, AI, and point-of-care ultrasound are paving the way for quality patient care during the post COVID-19 landscape. The echocardiography market is predicted to advance at a modest CAGR of ~4% during the forecast period, as AI and ML techniques need to overcome challenging regulatory body approval processes. Hence, med-tech companies should dive into large trials to provide robust evidence of ML and AI’s prognostic value in echocardiographic assessment before commercialization in clinical settings. As such, virtual face-to-face training for clinicians and their team hold promising potentials for market expansion in the upcoming years.
Echocardiography Market: Overview
The global echocardiography market was valued over US$ 1.4 Bn in 2019. The market is projected to expand at a moderate CAGR from 2020 to 2030.
Technological advancements, rise in prevalence of cardiovascular diseases across the world, increase in geriatric population, and surge in medical tourism in developing countries are anticipated to boost the global echocardiography market during the forecast period
Key players offering technological advanced product portfolios and their strong geographic presence is likely to propel the global echocardiography market. Major industry events, including partnerships, mergers & acquisitions, and collaborations are estimated to fuel the echocardiography market across the globe. Rise in awareness about early diagnosis and demand for treatment are anticipated to drive the global echocardiography market.
Echocardiography is a procedure that generates an electrocardiogram, also known as ECG or EKG. This is a highly common procedure used to study cardiovascular disease, and interpret the cardiac rhythm, detecting an infarction, myocardial infection, and other abnormalities in the heart. An electrocardiogram is preferred as it is a painless test to monitor heart health and its issues. An ECG machine is considered to be a standard equipment that is widely utilized in operating rooms and ambulances.
In other terms, electrocardiography is considered to be a quick and simple procedure that amplifies the heart’s electrical impulses, which are recorded. Electrocardiography is used to detect issues such as inadequate blood flow and abnormal rhythms. The procedure includes placing electrodes on the person’s arms, legs, and chest, which further measure the magnitude of electrical currents during each heartbeat.
Echocardiography Market: Segmentation
The global echocardiography market has been segmented based on test type, product type, technology, end user, and region
In terms of type, the global echocardiography market has been segregated into transthoracic echocardiogram, stress echocardiogram, transesophageal echocardiogram, and others. The others segment includes intravascular ultrasound and dobutamine stress echocardiogram. The transthoracic echocardiogram segment accounted for a prominent share of the market in 2019, as it is a highly common noninvasive type of echocardiogram, which uses high frequency sound waves (ultrasound) to create a moving picture of the heart through the chest wall; consequently, it is widely preferred for patients.
In terms of product type, the global echocardiography market has been classified into handheld/portable echocardiography devices and cart/trolley-based echocardiography devices. The cart/trolley-based echocardiography devices segment dominated the global echocardiography market in 2019, owing to an increase in the demand for technologically advanced echocardiography by multi-specialty and super-specialty hospitals.
Based on technology, the global echocardiography market has been categorized into 2D, 3D/4D, and Doppler. The Doppler segment accounted for a major share of the market in 2019, attributable to its various advantages such as it is non-invasive, generally painless, does not use harmful radiations, and can easily indicate the presence of a clot in the veins.
Based on end user, the global echocardiography market has been classified into hospitals, diagnostic centers, clinics, and others. The hospitals segment accounted for a notable share of the market in 2019, attributable to the frequent use of echocardiography devices across hospitals, as echocardiography is a highly common diagnostic tool used in cardiac care units in hospitals.
Echocardiography Market: Regional Segmentation
In terms of region, the global echocardiography market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
North America dominated the global echocardiography market in 2019. This is ascribed to high awareness about available medical treatments, significant infrastructure investment supporting medical treatments, and adoption of new and innovative products. Moreover, favorable government support for healthcare infrastructure and research & development of echocardiography are other key factors driving the market in the region.
The market in Asia Pacific is estimated to expand at a rapid pace during the forecast period. Presence of untapped opportunities and increase in awareness about disease conditions in Asia Pacific, along with the large population suffering from cardiovascular diseases in India and China contribute to the expansion of the market. Risk of cardiovascular disease in South Asia, India, China, and Australia is higher than that in Europe and North America, due to overweight/obesity, smoking, lifestyle habits, and increased blood sugar level in these countries and sub-region.
Echocardiography Market: Major Players
These players focus on adopting various strategies to expand product offerings and strengthen geographic presence across the globe. Technological advancements, mergers & acquisitions, expansion of product portfolio, growing research & development, and focus of companies in expanding their potential business are likely to boost their presence across the globe.
Key Questions Answered in Echocardiography Market Report
Echocardiography Market – Segmentation
Test Type
Product Type
End User
Region
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Echocardiography Market
4. Market Overview
4.1. Introduction
4.1.1. Market Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Echocardiography Market Analysis and Forecast, 2018–2030
4.4.1. Market Revenue Projections (US$ Bn)
5. Key Insights
5.1. Technological Advancements
5.2. Key Mergers & Acquisitions
5.3. Top 3 Players Operating in the Market Space
5.4. COVID-19 Pandemic Impact on Global Echocardiography Market
6. Global Echocardiography Market Analysis and Forecast, by Test Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
6.3.1. Transthoracic Echocardiogram
6.3.2. Stress Echocardiogram
6.3.3. Transesophageal Echocardiogram
6.3.4. Others
6.4. Market Attractiveness Analysis, by Test Type
7. Global Echocardiography Market Analysis and Forecast, by Product Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
7.3.1. Cart/trolley-based Echocardiography Devices
7.3.2. Handheld/portable Echocardiography Devices
7.4. Global Echocardiography Market Attractiveness Analysis, by Product Type
8. Global Echocardiography Market Analysis and Forecast, by Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Global Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
8.3.1. 2D
8.3.2. 3D & 4D
8.3.3. Doppler
8.4. Global Echocardiography Market Attractiveness Analysis, by Technology
9. Global Echocardiography Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Global Echocardiography Market Value (US$ Bn) Forecast, by End-user, 2018–2030
9.3.1. Hospitals
9.3.2. Diagnostic Centers
9.3.3. Clinics
9.3.4. Others
9.4. Global Echocardiography Market Attractiveness Analysis, by End-user
10. Global Echocardiography Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Global Echocardiography Market Value (US$ Bn) Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Echocardiography Market Attractiveness Analysis, by Region
11. North America Echocardiography Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. North America Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
11.2.1. Transthoracic Echocardiogram
11.2.2. Stress Echocardiogram
11.2.3. Transesophageal Echocardiogram
11.2.4. Others
11.3. North America Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
11.3.1. Cart/trolley-based Echocardiography Devices
11.3.2. Handheld/portable Echocardiography Devices
11.4. North America Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
11.4.1. 2D
11.4.2. 3D & 4D
11.4.3. Doppler
11.5. North America Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
11.5.1. Hospitals
11.5.2. Diagnostic Centers
11.5.3. Clinics
11.5.4. Others
11.6. North America Echocardiography Market Value (US$ Bn) Forecast, by Country, 2018–2030
11.6.1. U.S.
11.6.2. Canada
11.7. North America Echocardiography Market Attractiveness Analysis
11.7.1. By Test Type
11.7.2. By Product Type
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country
12. Europe Echocardiography Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Europe Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
12.2.1. Transthoracic Echocardiogram
12.2.2. Stress Echocardiogram
12.2.3. Transesophageal Echocardiogram
12.2.4. Others
12.3. Europe Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
12.3.1. Cart/trolley-based Echocardiography Devices
12.3.2. Handheld/portable Echocardiography Devices
12.4. Europe Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
12.4.1. 2D
12.4.2. 3D & 4D
12.4.3. Doppler
12.5. Europe Echocardiography Market Value (US$ Bn) Forecast, by End-user, 2018–2030
12.5.1. Hospitals
12.5.2. Diagnostic Centers
12.5.3. Clinics
12.5.4. Others
12.6. Europe Echocardiography Market Value (US$ Bn) Forecast, by Country/Sub-region, 2018–2030
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Echocardiography Market Attractiveness Analysis
12.7.1. By Test Type
12.7.2. By Product Type
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Echocardiography Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Asia Pacific Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
13.2.1. Transthoracic Echocardiogram
13.2.2. Stress Echocardiogram
13.2.3. Transesophageal Echocardiogram
13.2.4. Others
13.3. Asia Pacific Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
13.3.1. Cart/trolley-based Echocardiography Devices
13.3.2. Handheld/portable Echocardiography Devices
13.4. Asia Pacific Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
13.4.1. 2D
13.4.2. 3D & 4D
13.4.3. Doppler
13.5. Asia Pacific Echocardiography Market Value (US$ Bn) Forecast, by End-user, 2018–2030
13.5.1. Hospitals
13.5.2. Diagnostic Centers
13.5.3. Clinics
13.5.4. Others
13.6. Asia Pacific Echocardiography Market Value (US$ Bn) Forecast, by Country/Sub-region, 2018–2030
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Echocardiography Market Attractiveness Analysis
13.7.1. By Test Type
13.7.2. By Product Type
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Echocardiography Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Latin America Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
14.2.1. Transthoracic Echocardiogram
14.2.2. Stress Echocardiogram
14.2.3. Transesophageal Echocardiogram
14.2.4. Others
14.3. Latin America Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
14.3.1. Cart/trolley-based Echocardiography Devices
14.3.2. Handheld/portable Echocardiography Devices
14.4. Latin America Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
14.4.1. 2D
14.4.2. 3D & 4D
14.4.3. Doppler
14.5. Latin America Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
14.5.1. Hospitals
14.5.2. Diagnostic Centers
14.5.3. Clinics
14.5.4. Others
14.6. Latin America Echocardiography Market Value (US$ Bn) Forecast, by Country/Sub-region, 2018–2030
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Echocardiography Market Attractiveness Analysis
14.7.1. By Test Type
14.7.2. By Product Type
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Echocardiography Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Middle East & Africa Echocardiography Market Value (US$ Bn) Forecast, by Test Type, 2018–2030
15.2.1. Transthoracic Echocardiogram
15.2.2. Stress Echocardiogram
15.2.3. Transesophageal Echocardiogram
15.2.4. Others
15.3. Middle East & Africa Echocardiography Market Value (US$ Bn) Forecast, by Product Type, 2018–2030
15.3.1. Cart/trolley-based Echocardiography Devices
15.3.2. Handheld/portable Echocardiography Devices
15.4. Middle East & Africa Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
15.4.1. 2D
15.4.2. 3D & 4D
15.4.3. Doppler
15.5. Middle East & Africa Echocardiography Market Value (US$ Bn) Forecast, by Technology, 2018–2030
15.5.1. Hospitals
15.5.2. Diagnostic Centers
15.5.3. Clinics
15.5.4. Others
15.6. Middle East & Africa Echocardiography Market Value (US$ Bn) Forecast, by Country/Sub-region, 2018–2030
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Echocardiography Market Attractiveness Analysis
15.7.1. By Test Type
15.7.2. By Product Type
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competitive Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Company Profiles
16.2.1. GE Healthcare (Cart/trolley-based Echocardiography Devices Electric Company)
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Financial Overview
16.2.1.3. Product Portfolio
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Koninklijke Philips N.V.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Financial Overview
16.2.2.3. Product Portfolio
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. Siemens Healthcare Private Limited
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Financial Overview
16.2.3.3. Product Portfolio
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. Canon Medical Systems Corporation
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Financial Overview
16.2.4.3. Product Portfolio
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Esaote S.p.A
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Strategic Overview
16.2.5.4. SWOT Analysis
16.2.6. Samsung Electronics Co., Ltd.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Financial Overview
16.2.6.3. Product Portfolio
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. Fujifilm Holdings Corporation
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Financial Overview
16.2.7.3. Product Portfolio
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Hitachi Medical Corporation
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Financial Overview
16.2.8.3. Product Portfolio
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Strategic Overview
16.2.9.4. SWOT Analysis
16.2.10. Bay Labs, Inc.
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. Strategic Overview
16.2.10.4. SWOT Analysis
16.2.11. Bracco Imaging S.p.A.
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. Strategic Overview
16.2.11.4. SWOT Analysis
16.2.12. ContextVision AB
16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.12.2. Financial Overview
16.2.12.3. Product Portfolio
16.2.12.4. Strategic Overview
16.2.12.5. SWOT Analysis
16.2.13. Digirad Corporation
16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.13.2. Product Portfolio
16.2.13.3. Strategic Overview
16.2.13.4. SWOT Analysis
16.2.14. TELEMED Medical Systems
16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.14.2. Product Portfolio
16.2.14.3. Strategic Overview
16.2.14.4. SWOT Analysis